Filing Details
- Accession Number:
- 0001127602-15-020521
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-11 18:29:51
- Reporting Period:
- 2015-06-11
- Filing Date:
- 2015-06-11
- Accepted Time:
- 2015-06-11 18:29:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
711404 | Cooper Companies Inc | COO | Ophthalmic Goods (3851) | 942657368 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1536574 | W Gregory Matz | 6140 Stoneridge Mall Road, Suite 590 Pleasanton CA 94588 | Svp, Cfo & Cro | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-06-11 | 10,000 | $38.89 | 22,975 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-06-11 | 1,800 | $174.70 | 21,175 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-11 | 3,001 | $175.47 | 18,174 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-11 | 5,199 | $176.62 | 12,975 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2015-06-11 | 10,000 | $0.00 | 10,000 | $38.89 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
13,750 | 2020-05-02 | No | 4 | M | Direct |
Footnotes
- Sold pursuant to a 10b5-1 plan adopted 7/14/14.
- The price represents an average of sale prices between $174.05 and $175.04.
- The price represents an average of sale prices between $175.08 and $175.92.
- The price represents an average of sale prices between $176.11 and $176.99.
- 5/3/2010 NQ Grant: The options will vest in equal increments over four years measured from the date of grant as follows: 1/4 shall vest on 5/3/2011; 1/4 shall vest on 5/3/2012; 1/4 shall vest on 5/3/2013; and 1/4 shall vest on 5/3/2014.